[go: up one dir, main page]

MX9603034A - Producto farmaceutico que comprende un salicilato de un bloqueador beta esterificable. - Google Patents

Producto farmaceutico que comprende un salicilato de un bloqueador beta esterificable.

Info

Publication number
MX9603034A
MX9603034A MX9603034A MX9603034A MX9603034A MX 9603034 A MX9603034 A MX 9603034A MX 9603034 A MX9603034 A MX 9603034A MX 9603034 A MX9603034 A MX 9603034A MX 9603034 A MX9603034 A MX 9603034A
Authority
MX
Mexico
Prior art keywords
esterifiable
beta
blocker
salicylate
pharmaceutical product
Prior art date
Application number
MX9603034A
Other languages
English (en)
Other versions
MXPA96003034A (es
Inventor
William Byrne
Andrew Rynne
Original Assignee
Cal Internat Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cal Internat Ltd filed Critical Cal Internat Ltd
Publication of MX9603034A publication Critical patent/MX9603034A/es
Publication of MXPA96003034A publication Critical patent/MXPA96003034A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/02—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C219/04—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C219/14—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the hydroxy groups esterified by a carboxylic acid having the esterifying carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

Se describen salicilatos de bloqueadores beta esterificables, especialmente Atenolol-O-Aspirinato, Metoprolol-O-Aspirinato, Pindolol-O-Aspirinato, y procesos para su preparacion.
MXPA/A/1996/003034A 1994-01-28 1996-07-26 Producto farmaceutico que comprende un salicilatode un bloqueador beta esterificable MXPA96003034A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IE940079 1994-01-28
IE940079 1994-01-28
PCT/IE1995/000011 WO1995020568A1 (en) 1994-01-28 1995-01-27 Pharmaceutical product comprising a salicylate of an esterifiable beta-blocker

Publications (2)

Publication Number Publication Date
MX9603034A true MX9603034A (es) 1998-05-31
MXPA96003034A MXPA96003034A (es) 1998-10-23

Family

ID=

Also Published As

Publication number Publication date
CA2182219A1 (en) 1995-08-03
WO1995020568A1 (en) 1995-08-03
ZA95704B (en) 1995-10-25
GB9616298D0 (en) 1996-09-11
EP0750608A1 (en) 1997-01-02
AU1670895A (en) 1995-08-15
JPH09508378A (ja) 1997-08-26
GB2300636A (en) 1996-11-13

Similar Documents

Publication Publication Date Title
IL98472A0 (en) Dialkoxy-pyridinyl-benzimidazole derivatives,process for their preparation and their pharmaceutical use
GR3032732T3 (en) Amido-3-pyrazole derivatives, process for their preparation and pharmaceutical compositions containing them.
AU3173095A (en) Novel pharmaceutical product
ZA901602B (en) Novel benzimidazole and azabenzimidazole derivatives,preparation intermediates and pharmaceuticals
ZA914296B (en) Dialkoxy-pyridinyl-benzimidazole derivatives,process for their preparation and their pharmaceutical use
GR3014958T3 (en) 2,4- and 2,5-Pyridine-dicarboxylic-acid derivatives, process for their preparation, their use and medicines based on these compounds.
ZA953701B (en) New atagonist compounds
CS210291A3 (en) Benzeneacetamide derivatives, process for their preparation and pharmaceuticals based on them
AU6675490A (en) Heterocyclic derivatives, their preparation and medicinal products containing them
HUP9602635A2 (en) 4-aciloxy-benzenesulfonamide derivatives, process for their preparation and pharmaceutical compositions containing them
AU6611396A (en) New oxazolidinone derivatives, processes for the production thereof and pharmaceutical agents containing these compounds
AU1161292A (en) Azabicydic and azatricydic derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them
AU1122688A (en) Substituted 3,4-dihydro-2h-benzopyrans, processes for their preparation, their use and pharmaceutical products based on these compounds
HUP9901485A3 (en) Heterocyclylcarboxamide derivatives, pharmaceutical compositions containing the same, process for their preparation and their use
AU4352193A (en) Novel aminopropanol derivatives, pharmaceutical compositions containing them and process for preparing same
EP0278452A3 (en) 2,4- and 2,5-pyridine-dicarboxylic-acid derivatives, process for their preparation, their use and medicines based on these compounds
CS265391A3 (en) Novel thienodiazepines, process for their preparation and pharmaceutical comprising them
GB2300636A (en) Pharmaceutical product comprising a salicylate of an esterifiable beta-blocker
LTIP760A (en) Novel thienothiazine derivatives, process for preparing thereof and pharmaceutical preparations
AU8917891A (en) Poly-aminopyrrolecarboxamido derivatives, processes for their preparation and pharmaceutical compositions containing them
HUP9801068A3 (en) 1,2,3,4-tetrahydro-2-naphtaleneamine derivatives, process for their preparation, their use, and pharmaceutical compositions containing them
GB2235198B (en) Novel aminopropanol derivatives,process for their preparation and pharmaceutical compositions comprising the same
HRP960532A2 (en) Novel imidazole n-benzyldioxol derivatives, method for preparing the same, their use as medicaments, pharmaceutical preparations and novel use
HUP9600173A3 (en) 4-amino-benzoyl-guanidine derivatives, process for preparing them and pharmaceutical compositions containing them
HUT67089A (en) Acyl-oxy-hexanic acid derivatives and process for prepg. said compd. and pharmaceutical compn. contg. them